NHD Global
Reproductive & Hormone · Source-reviewed dossier
Source-Reviewed Research Dossier
Gonadorelin acetate is a man-made version of gonadorelin, a small protein the brain's hypothalamus naturally makes. It tells the nearby pituitary gland to release two hormones that signal the ovaries or testes. Researchers study it to understand how the brain controls fertility, puberty and hormone cycles, and why the same molecule can either turn this system on or shut it down depending on how it is given. Published human work describes its role in reproductive physiology. Catalog gonadorelin acetate is a research material, and its identity and quality are set by specification documents rather than clinical literature.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; request the applicable product specification and ask which lot records are available before ordering.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. Confirm the supplied form, formula, molecular weight, purity and storage conditions against the applicable product specification and any available lot records.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A current physiology review describes the native human GnRH-I sequence and its control of downstream gonadotropins.
Physiology does not establish efficacy of an unapproved supplied material.
Read the primary studyA review details GnRH-receptor signaling, desensitization and reproductive applications.
Analogue pharmacology should not be assigned to native gonadorelin without qualification.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Single-component peptide · 2 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
A listed document is not proof of availability for this lot. Ask the team to confirm the current COA status and the scope of any other records before ordering.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
Physiology does not establish efficacy of an unapproved supplied material.
View primary recordAnalogue pharmacology should not be assigned to native gonadorelin without qualification.
View primary recordThird-party publications selected for direct relevance.
StatPearls review. PMID 32644418.
Review. 2023. PMID 37958948.
Concise answers for researchers comparing identity, evidence and catalog variants.
Published research describes gonadorelin as the brain signal that controls pituitary release of luteinizing hormone and follicle-stimulating hormone. Its effects depend on exposure pattern: short pulses support hormone release, while continuous stimulation can make the pituitary less responsive and lower sex hormones. Reviews also map its receptors in pituitary and some other tissues. These are findings from specific models and do not establish a general health effect for a research material.
Gonadorelin receptors are not only in the pituitary. They have been described in reproductive tissues such as ovary, uterus and prostate, and in other tissues including heart, muscle, liver and melanoma cells. This wider distribution is an active research area. However, finding a receptor in a tissue does not prove a health effect. Any findings in these tissues remain limited to the specific models studied and should not be assumed to apply to people.
Human physiology and clinical literature are substantial, but formulation, dosing pattern and indication determine interpretation.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge center
Owned educational content connected to this family.
Gonadorelin is synthetic GnRH. Its evidence cannot be summarized without exposure pattern: pulsatile signaling can support gonadotropin release, while sustained stimulation can produce receptor…
Updated October 1, 2026
Gonadorelin is the native-sequence GnRH decapeptide with N-terminal pyroglutamate and C-terminal glycinamide. Both terminal modifications are identity-defining.
Updated October 1, 2026Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: GND2 · 2 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
